These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 29125235)

  • 1. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.
    Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I
    Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia.
    Cui B; Chen L; Zhang S; Mraz M; Fecteau JF; Yu J; Ghia EM; Zhang L; Bao L; Rassenti LZ; Messer K; Calin GA; Croce CM; Kipps TJ
    Blood; 2014 Jul; 124(4):546-54. PubMed ID: 24914134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.
    Alfarano A; Indraccolo S; Circosta P; Minuzzo S; Vallario A; Zamarchi R; Fregonese A; Calderazzo F; Faldella A; Aragno M; Camaschella C; Amadori A; Caligaris-Cappio F
    Blood; 1999 Apr; 93(7):2327-35. PubMed ID: 10090943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD5 does not regulate the signaling triggered through BCR in B cells from a subset of B-CLL patients.
    Perez-Chacon G; Vargas JA; Jorda J; Alvarez N; Martin-Donaire T; Rosado S; Losada-Fernandez I; Rebolleda N; Perez-Aciego P
    Leuk Lymphoma; 2007 Jan; 48(1):147-57. PubMed ID: 17325858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia.
    Chen L; Widhopf G; Huynh L; Rassenti L; Rai KR; Weiss A; Kipps TJ
    Blood; 2002 Dec; 100(13):4609-14. PubMed ID: 12393534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
    Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I
    Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal B cells express ZAP70 in chronic lymphocytic leukemia: A link between autoimmunity and lymphoproliferation?
    Ghergus D; Martin M; Knapp AM; Delmotte F; Joublin-Delavat A; Jung S; Schickel JN; Mendel I; Dupuis A; Drénou B; Ghesquières H; Salles G; Baseggio L; Herbrecht R; Korganow AS; Vallat L; Soulas-Sprauel P; Meffre E; Martin T
    Am J Hematol; 2024 Jan; 99(1):48-56. PubMed ID: 37853951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of B-cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells.
    Renaudineau Y; Nédellec S; Berthou C; Lydyard PM; Youinou P; Pers JO
    Leukemia; 2005 Feb; 19(2):223-9. PubMed ID: 15618965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic variation of CD5 surface expression levels within individual chronic lymphocytic leukemia clones.
    Bashford-Rogers RJ; Palser AL; Hodkinson C; Baxter J; Follows GA; Vassiliou GS; Kellam P
    Exp Hematol; 2017 Feb; 46():31-37.e10. PubMed ID: 27693386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of ZAP70 in chronic lymphocytic leukaemia activates NF-κB signalling.
    Pede V; Rombout A; Vermeire J; Naessens E; Vanderstraeten H; Philippé J; Verhasselt B
    Br J Haematol; 2013 Dec; 163(5):621-30. PubMed ID: 24219331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNA.
    Stamatopoulos B; Haibe-Kains B; Equeter C; Meuleman N; Sorée A; De Bruyn C; Hanosset D; Bron D; Martiat P; Lagneaux L
    Haematologica; 2009 Jun; 94(6):790-9. PubMed ID: 19377082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase δ but not SYK or BTK in chronic lymphocytic leukemia cells.
    Till KJ; Pettitt AR; Slupsky JR
    J Immunol; 2015 Mar; 194(5):2439-46. PubMed ID: 25632006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural phosphorylation of CD5 in chronic lymphocytic leukemia B cells and analysis of CD5-regulated genes in a B cell line suggest a role for CD5 in malignant phenotype.
    Gary-Gouy H; Sainz-Perez A; Marteau JB; Marfaing-Koka A; Delic J; Merle-Beral H; Galanaud P; Dalloul A
    J Immunol; 2007 Oct; 179(7):4335-44. PubMed ID: 17878328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
    Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R
    Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemia.
    Wagner M; Oelsner M; Moore A; Götte F; Kuhn PH; Haferlach T; Fiegl M; Bogner C; Baxter EJ; Peschel C; Follows GA; Ringshausen I
    Blood; 2016 Jan; 127(4):436-48. PubMed ID: 26508782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia.
    Thompson AA; Talley JA; Do HN; Kagan HL; Kunkel L; Berenson J; Cooper MD; Saxon A; Wall R
    Blood; 1997 Aug; 90(4):1387-94. PubMed ID: 9269755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SYK and ZAP70 kinases in autoimmunity and lymphoid malignancies.
    Leveille E; Chan LN; Mirza AS; Kume K; Müschen M
    Cell Signal; 2022 Jun; 94():110331. PubMed ID: 35398488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling.
    Dielschneider RF; Xiao W; Yoon JY; Noh E; Banerji V; Li H; Marshall AJ; Johnston JB; Gibson SB
    Cell Death Dis; 2014 Oct; 5(10):e1439. PubMed ID: 25275600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL.
    Lanasa MC; Allgood SD; Slager SL; Dave SS; Love C; Marti GE; Kay NE; Hanson CA; Rabe KG; Achenbach SJ; Goldin LR; Camp NJ; Goodman BK; Vachon CM; Spector LG; Rassenti LZ; Leis JF; Gockerman JP; Strom SS; Call TG; Glenn M; Cerhan JR; Levesque MC; Weinberg JB; Caporaso NE
    Leukemia; 2011 Sep; 25(9):1459-66. PubMed ID: 21617698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL.
    Nichols EM; Jones R; Watson R; Pepper CJ; Fegan C; Marchbank KJ
    Oncotarget; 2015 Oct; 6(32):32669-80. PubMed ID: 26452134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.